PYY and kidney disorder: SCFAs participate in the maintenance of intestinal mucosal integrity, improve glucose and lipid metabolism, increase the secretion of glucagon-like peptide-1 (GLP-1) and peptide YY (PYY), and regulate the immune system and inflammatory responses, as such, they confer protection against cardiometabolic and kidney disease [30].